What's another year to such a storied company? Let's have a look at how 2011 treated the chemical giant.
Just the numbers
From a fundamental point of view, DuPont is doing mighty fine. The company has beaten Wall Street's earnings estimates in each of its quarterly reports this year by an average of 14%. GAAP earnings are up by 10% year over year in spite of heavy integration costs from a big acquisition.
The $5.8 billion deal for Danish food-ingredients giant Danisco is transformative even for a company of DuPont's stature and size. The American food-chemicals market has belonged to Monsanto
DuPont also bought silicon-ink maker Innovalight from a consortium of venture backers that included nanotech expert Harris & Harris
So DuPont is keeping an eye on the horizon ahead, not content to rest on its considerable laurels. That's why this is a stock to hold for the next 10 years and beyond. This is exactly the kind of rock-solid stock that will help your retirement portfolio survive the end of Social Security and Medicare.
Fool contributor Anders Bylund holds no position in any of the companies mentioned. Motley Fool newsletter services have recommended buying shares of Universal Display and creating a synthetic long position in Monsanto. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinion, but we all believe that considering a diverse range of insights makes us better investors. Check out Anders' holdings and bio, or follow him on Twitter and Google+. We have a disclosure policy.